KRAS and ovarian carcinoma: Interestingly, both patients with SD ≥ 4 months harbored EGFR aberrations, including an ovarian cancer patient with KRAS G12D and EGFR G724S mutations and a salivary gland cancer patient with EGFR amplification by IHC.